TC
NUTX

Truvestments Capital’s Nutex Health NUTX Stock Holding History

Truvestments Capital’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.86K Buy
+46
New +$5.83K ﹤0.01% 829

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Truvestments Capital's NUTX Position: Q2 2026 in Review

Truvestments Capital opened a new position in Nutex Health (NUTX) in Q2 2026: 46 shares worth $7.86K. The stake represents ﹤0.01% of the portfolio and ranks #829 among its holdings.

154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Truvestments Capital held 46 shares of Nutex Health worth $7.86K as of Q2 2026.
  • Nutex Health was a new Truvestments Capital position in Q2 2026.
  • Nutex Health made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #829 holding.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.